This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2019.
Company Filing History:
1 out of 834,411 Years Active: 2019
Title: Innovations of Hongjun Ren in Anticancer Drug Development
Introduction
Hongjun Ren is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer drugs. His innovative work has led to the creation of a unique compound that shows promise in cancer treatment.
Latest Patents
Hongjun Ren holds 1 patent for his invention titled "Spirocyclic indolone polyethylene glycol carbonate compound, composition, preparation method and use thereof." This invention relates to a spirocyclic indolone polyethylene glycol carbonate compound that exhibits antitumor activity. The compound is characterized by excellent tumor inhibitory activity, water solubility, and low toxicity, making it suitable for intravenous injection.
Career Highlights
Throughout his career, Hongjun Ren has worked with various organizations, including Jiangsu Yayo Biotechnology Co., Ltd. His expertise in the field has allowed him to contribute to advancements in drug development and therapeutic applications.
Collaborations
Hongjun Ren has collaborated with notable colleagues such as Jie Ma and Fei Xiao. Their combined efforts have furthered research and innovation in the field of anticancer therapies.
Conclusion
Hongjun Ren's contributions to the development of anticancer drugs highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire advancements in medicinal chemistry and cancer treatment.